Turkey considers third dose in Pfizer-BioNTech coronavirus jab 

  06 October 2021    Read: 134
Turkey considers third dose in Pfizer-BioNTech coronavirus jab 

Turkey has started administering third doses of inactive CoronaVac vaccine and now plans to administer third or booster shots for the Pfizer-BioNTech jab, the second vaccine available in Turkey, AzVision.az reports citing Daily Sabah.

A report published by the Hürriyet newspaper on Tuesday says the Health Ministry's Coronavirus Scientific Advisory Group discussed the matter and the ministry would soon announce the eligibility rules for third doses.

The booster shots aim to revive the impact of the vaccine on immunity and studies suggest that two doses of vaccine lose their efficiency within six months after the second dose.

Israel was the first country to offer the third dose of the Pfizer-BioNTech Messenger RNA (mRNA) vaccine while the Food and Drugs Administration (FDA) in the United States approved the third dose for the elderly and people under risk.

The report says Turkey will decide on third doses after the results of a nationwide study that examines the antibody levels. The study will also serve as a guide for a decision on whether people who have had two doses of CoronaVac and a third dose of Pfizer-BioNTech vaccine will require a fourth shot.


More about: Turkey   coronavirus   vaccine